StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Cost of sales — Total by Quarter

Cost of sales — Total ($M) ($M)

QuarterlyAnnual

Vertex Pharmaceuticals Cost of sales — Total: $489M in Q2 2026, up 20.0% from a year earlier. That is the highest of the 63 quarters on record here.

Latest, Q2 2026
489
Period ended Jun 30, 2026
Change on a year earlier
+20.0%
408 in Q2 2025
History
63 quarters
Since Q2 2010
Sources
46
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K Consolidated Statements of Operations & Segment Note.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCost of sales — Total ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026489+20.0%Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 31, 2026393+8.2%Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 2025466+10.1%Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 2025415+5.7%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 2025408+9.6%Form 10-Q (filed 2026-08-04) ↗
Q1 2025Mar 31, 2025363+6.0%Form 10-Q (filed 2026-05-05) ↗
Q4 2024Dec 31, 2024423+15.1%Form 10-K (filed 2026-02-13) ↗
Q3 2024Sep 30, 2024393+23.2%Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 2024372+20.5%Form 10-Q (filed 2025-08-05) ↗
Q1 2024Mar 31, 2024343+28.4%Form 10-Q (filed 2025-05-06) ↗
Q4 2023Dec 31, 2023368+29.9%Form 10-K (filed 2026-02-13) ↗
Q3 2023Sep 30, 2023319+10.1%Form 10-Q (filed 2024-11-05) ↗
Q2 2023Jun 30, 2023309+17.9%Form 10-Q (filed 2024-08-02) ↗
Q1 2023Mar 31, 2023267+8.6%Form 10-Q (filed 2024-05-07) ↗
Q4 2022Dec 31, 2022283+14.5%Form 10-K (filed 2025-02-13) ↗
Q3 2022Sep 30, 2022289+22.4%Form 10-Q (filed 2023-11-07) ↗

Breakdown

What makes up cost of sales — Total

Cite this data

StockData. (2026). Vertex Pharmaceuticals Cost of sales — Total ($M), quarterly Q2 2010–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/seg-cogs-tot

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.